ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Earnings Avalanche: Auto and Big Tech in Focus

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Apple kicks off the week's biggest test. The $5 trillion company reports after Monday's close. Analysts will scrutinise services revenue and iPhone demand as the holiday quarter begins.

Amgen follows Monday evening. The biotech giant, worth $252 billion, holds its earnings call. Sony is due Tuesday, with the Japanese conglomerate reporting after its Tokyo session.

Wednesday brings Ferrari to the track. The Italian carmaker reports 3 November. ORTEX alt data flags a potential headwind: Austrian car registration data, which leads Ferrari's revenue by 22 days, is running 75% below the same quarter last year across all three months so far. That is the weakest reading for any auto name in the dataset this week.

Allstate and Advance Auto Parts both report Thursday. Also Thursday: Polestar posts results. Dutch car registrations, a leading indicator for Polestar's revenue with a strong 60-day lead time, are running 37% below last year.

Honda and Charter Communications close the week Thursday evening and Friday respectively.

No IPOs were found in the database for the next seven days.

On the index front, today is the Russell 2000 December review rank date. Life Time Group Holdings and UMB Financial have both hit 90% deletion odds overnight, carrying a combined $2.2 billion of potential forced selling if prices hold.

Stocks in this article

How this article was generated

Generated
31 Oct 2026, 20:31
Prompt version
v1.0
Data sources
EarningsAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.